SG11201604840TA - Prophylactic and/or therapeutic agent for functional gastrointestinal disorders - Google Patents

Prophylactic and/or therapeutic agent for functional gastrointestinal disorders

Info

Publication number
SG11201604840TA
SG11201604840TA SG11201604840TA SG11201604840TA SG11201604840TA SG 11201604840T A SG11201604840T A SG 11201604840TA SG 11201604840T A SG11201604840T A SG 11201604840TA SG 11201604840T A SG11201604840T A SG 11201604840TA SG 11201604840T A SG11201604840T A SG 11201604840TA
Authority
SG
Singapore
Prior art keywords
prophylactic
therapeutic agent
gastrointestinal disorders
functional gastrointestinal
functional
Prior art date
Application number
SG11201604840TA
Inventor
Yasuhiro Koga
Atsushi Takagi
Toshihiro Ohtsu
Original Assignee
Meiji Co Ltd
Univ Tokai Educational System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Co Ltd, Univ Tokai Educational System filed Critical Meiji Co Ltd
Publication of SG11201604840TA publication Critical patent/SG11201604840TA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
SG11201604840TA 2014-02-28 2015-02-27 Prophylactic and/or therapeutic agent for functional gastrointestinal disorders SG11201604840TA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2014038586 2014-02-28
PCT/JP2015/001042 WO2015129281A1 (en) 2014-02-28 2015-02-27 Prophylactic and/or therapeutic agent for functional gastrointestinal disorders

Publications (1)

Publication Number Publication Date
SG11201604840TA true SG11201604840TA (en) 2016-09-29

Family

ID=54008612

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201604840TA SG11201604840TA (en) 2014-02-28 2015-02-27 Prophylactic and/or therapeutic agent for functional gastrointestinal disorders

Country Status (5)

Country Link
JP (2) JP6781887B2 (en)
CN (1) CN106029081A (en)
HK (1) HK1225637A1 (en)
SG (1) SG11201604840TA (en)
WO (1) WO2015129281A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20190151381A1 (en) * 2016-06-20 2019-05-23 Meiji Co., Ltd. Upper gastrointestinal flora-improving agent
JP6813974B2 (en) * 2016-07-14 2021-01-13 株式会社明治 Ghrelin secretagogue
CN110402289A (en) * 2016-12-27 2019-11-01 株式会社明治 Utilize flora improver in the detection method of the functional digestive disorder of the occupation rate measurement of flora in stomach and stomach
JP7280069B2 (en) 2018-03-28 2023-05-23 森永乳業株式会社 A composition for preventing or improving functional gastrointestinal disorders, and pharmaceutical compositions and food and drink compositions using the composition for preventing or improving functional gastrointestinal disorders
JP6515244B2 (en) * 2018-11-14 2019-05-15 株式会社明治 Ghrelin secretagogue
CN114525222A (en) * 2022-03-02 2022-05-24 山东拜因诺生物科技有限公司 Youyou-suppressing probiotics

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4509250B2 (en) * 1999-06-24 2010-07-21 明治乳業株式会社 Helicobacter pylori sanitizing medicine
KR101307864B1 (en) * 2005-07-21 2013-09-12 가부시키가이샤 야쿠르트 혼샤 Novel bacterium belonging to the genus bifidobacterium and utilization of the same
CN101998834B (en) * 2007-10-11 2017-05-10 杜邦营养生物科学有限公司 Probiotics for use in relieving symptoms associated with gastrointestinal disorders
BR112012018813B1 (en) * 2010-01-28 2020-12-08 Ab-Biotics S.A. composition comprising bacterial strains with anti-inflammatory, immunomodulating, anti-abdominal or anti-distension properties, use of these strains, as well as pharmaceutical, veterinary and edible products comprising said composition
JP5300772B2 (en) * 2010-03-26 2013-09-25 森永乳業株式会社 Novel lactic acid bacteria and pharmaceuticals, foods and drinks, and feeds containing the novel lactic acid bacteria
JP5631721B2 (en) * 2010-12-17 2014-11-26 ビオフェルミン製薬株式会社 Gastrointestinal hypersensitizer
JP5075254B2 (en) * 2011-01-07 2012-11-21 スノーデン株式会社 Lactic acid bacteria that suppress the production of gastric acid and gastrin

Also Published As

Publication number Publication date
JP2018184481A (en) 2018-11-22
JP6781887B2 (en) 2020-11-11
JPWO2015129281A1 (en) 2017-03-30
WO2015129281A1 (en) 2015-09-03
CN106029081A (en) 2016-10-12
HK1225637A1 (en) 2017-09-15

Similar Documents

Publication Publication Date Title
HK1253877A1 (en) Devices for gastrointestinal stimulation and uses thereof
IL250685A0 (en) Cytotoxicity-inducing therapeutic agent
HK1243073A1 (en) Therapeutic compounds and uses thereof
IL249370A0 (en) Fap-activated therapeutic agents, and uses related thereto
HK1251183A1 (en) Bioconjugates and uses thereof
PT3132034T (en) Therapeutic
SG11201609490QA (en) Polymer-flavonoid conjugate and uses thereof
HK1225637A1 (en) Prophylactic and/or therapeutic agent for functional gastrointestinal disorders
IL251904B (en) Apilimod for use in the treatment of melanoma
GB201410216D0 (en) Therapeutic
PT3160464T (en) 6-hydroxybuspirone for use in the treatment of movement disorders
GB201404372D0 (en) Assay and treatment
GB201510637D0 (en) Therapeutic
GB201418809D0 (en) Therapeutic agents and uses thereof
IL250160A0 (en) Pharmaceutical agent
EP3204003A4 (en) Selenosugars and therapeutic uses thereof
GB201411150D0 (en) Novel aptamers and therapeutic uses thereof
PL3562548T3 (en) Therapeutic device
GB201612549D0 (en) Therapeutic device
GB201419559D0 (en) Therapeutic compositions and methods
GB201417777D0 (en) Novel compounds and therapeutic uses thereof
GB201418508D0 (en) Therapeutic
GB201413719D0 (en) Therapeutic
AU2014901186A0 (en) Therapeutic Agents and Uses Thereof
GB201410832D0 (en) Therapeutic